Table 1 Compositions of the desired NLC formulations.
Formulation | Lipid phase | Aqueous phase | ||||
|---|---|---|---|---|---|---|
Olivem 1000 | Miglyol C-T7 | OXR or DHO | Tween 80 | Microcare PHC | DI water | |
Blank-NLC | 2 | 8 | – | 4 | 1 | 85 |
OXR-NLC | 2 | 8 | 0.3 | 4 | 1 | 84.7 |
DHO-NLC | 2 | 8 | 0.3 | 4 | 1 | 84.7 |
Formulation | Lipid phase | Aqueous phase | ||||
|---|---|---|---|---|---|---|
Olivem 1000 | Miglyol C-T7 | OXR or DHO | Tween 80 | Microcare PHC | DI water | |
Blank-NLC | 2 | 8 | – | 4 | 1 | 85 |
OXR-NLC | 2 | 8 | 0.3 | 4 | 1 | 84.7 |
DHO-NLC | 2 | 8 | 0.3 | 4 | 1 | 84.7 |